Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Drug Resistance

Free Subscription Articles published in J Virol Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

March 2012
1. ANDREI G , Topalis D, Fiten P, McGuigan C, et al
   In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
   J Virol. 2012;86:2641-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
2. PAN D , Coen DM
   Quantification and Analysis of Thymidine Kinase Expression from Acyclovir-Resistant G-String Insertion and Deletion Mutants in Herpes Simplex Virus-Infected Cells.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. QUASHIE PK , Mesplede T, Han Y, Oliveira M, et al
   Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor Dolutegravir.
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. PERALES C , Henry M, Domingo E, Wain-Hobson S, et al
   Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space.
   J Virol. 2011;85:12227-40.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. PUTCHAROEN O , Lee SH, Henrich TJ, Hu Z, et al
   HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics that Correct in the Presence of Drug.
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. XIE X , Wang QY, Xu HY, Qing M, et al
   Inhibition of dengue virus by targeting viral NS4B protein.
   J Virol. 2011;85:11183-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. YU X , Lu L, Cai L, Tong P, et al
   Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting gp41 pocket.
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GINTING TE , Shinya K, Kyan Y, Makino A, et al
   Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. WANG W , De Feo CJ, Zhuang M, Vassell R, et al
   Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of human immunodeficiency virus type 1 (HIV-1) gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. LAM AM , Espiritu C, Bansal S, Micolochick Steuer HM, et al
    HCV Nucleotide Inhibitors PSI-352938 and PSI-353661 Exhibit a Novel Mechanism of Resistance Requiring Multiple Mutations within Replicon RNA.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
11. XU HT , Asahchop EL, Oliveira M, Quashie PK, et al
    Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase of Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. HU Z , Kuritzkes DR
    Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. EGGINK D , Bontjer I, Langedijk JP, Berkhout B, et al
    Human immunodeficiency virus type 1 resistance to a third generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KOH Y , Aoki M, Danish ML, Aoki-Ogata H, et al
    LOSS OF DARUNAVIR'S PROTEASE DIMERIZATION INHIBITION ACTIVITY IS ASSOCIATED WITH HIV-1 ACQUISITION OF RESISTANCE TO DARUNAVIR.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. FUSARO A , Monne I, Salviato A, Valastro V, et al
    Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications.
    J Virol. 2011;85:8413-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
16. GOLDNER T , Hewlett G, Ettischer N, Ruebsamen-Schaeff H, et al
    The novel Anti-Cytomegalovirus Compound AIC246 inhibits HCMV Replication through a Specific Antiviral Mechanism that involves the viral Terminase.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
17. BERRO R , Klasse PJ, Lascano D, Flegler A, et al
    Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CASTRO EF , Fabian LE, Caputto ME, Gagey D, et al
    Inhibition of bovine viral diarrhea virus RNA synthesis by thiosemicarbazone derived from 5,6-dimethoxy-1-indanone.
    J Virol. 2011;85:5436-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. CONG ME , Youngpairoj AS, Zheng Q, Aung W, et al
    Protection against Rectal Transmission of an Emtricitabine (FTC)-Resistant SHIV162p3M184V Mutant by Intermittent Prophylaxis with Truvada.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GIANELLA S , Delport W, Pacold ME, Young JA, et al
    Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection Rather than Transmission and Evolution of Multiple Viral Variants.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
21. IBARRA KD , Jain MK, Pfeiffer JK
    Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.
    J Virol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
22. FUNAOKA Y , Sakamoto N, Suda G, Itsui Y, et al
    Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WANG D , Hicks CB, Goswami N, Tafoya E, et al
    Evolution of Drug-resistant Viral Populations during Interruption of Antiretroviral Therapy.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
24. GASTAMINZA P , Pitram SM, Dreux M, Krasnova LB, et al
    Antiviral Stilbene 1,2-Diamines Prevent Initiation Of Hepatitis C Viral RNA Replication At The Outset of Infection.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. KISO M , Ozawa M, Le MT, Imai H, et al
    Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MARTIN-ACEBES MA , Vazquez-Calvo A, Rincon V, Mateu MG, et al
    A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance.
    J Virol. 2011;85:2733-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
27. ROCHE M , Jakobsen MR, Sterjovski J, Ellett A, et al
    HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less efficient mechanism of gp120-CCR5 engagement that attenuates macrophage-tropism.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. TOMA J , Weinheimer SP, Stawiski E, Whitcomb JM, et al
    Loss of Asparagine-Linked Glycosylation Sites in Variable Region Five of Human Immunodeficiency Virus Type 1 Envelope is Associated with Resistance to CD4 Antibody Ibalizumab.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SHUCK-LEE D , Chang H, Sloan EA, Hammarskjold ML, et al
    Single Nucleotide Changes in the HIV RRE Mediate Resistance to Compounds That Inhibit Rev Function.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
30. BASU A , Li B, Mills DM, Panchal RG, et al
    Identification of a Small-Molecule Entry Inhibitor for Filoviruses.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KOH Y , Matreyek KA, Engelman A
    Differential sensitivities of retroviruses to integrase strand transfer inhibitors.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. LARA J , Xia G, Purdy M, Khudyakov Y, et al
    Coevolution of the Hepatitis C Virus Polyprotein Sites in Patients on Combined Pegylated Interferon and Ribavirin Therapy.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
33. BARRERO PR , Viegas M, Valinotto LE, Mistchenko AS, et al
    Genetic and phylogenetic analyses of Influenza A H1N1pdm in Buenos Aires, Argentina.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. STANSELL E , Canis K, Haslam SM, Dell A, et al
    Simian Immunodeficiency Virus from Sooty Mangabey and Rhesus Macaque is Modified with O-linked Carbohydrate.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
35. KOH Y , Amano M, Towata T, Danish M, et al
    In Vitro Selection of Highly Darunavir-Resistant and Replication -Competent HIV-1 Variants Using a Mixture of Clinical HIV-1 Isolates Resistant To Multiple Conventional Protease Inhibitors.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
36. SEIBERT CW , Kaminski M, Philipp J, Rubbenstroth D, et al
    Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. WELCH BD , Francis JN, Redman JS, Paul S, et al
    Design of a Potent D-peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. TILTON JC , Wilen CB, Didigu CA, Sinha R, et al
    A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
39. GADHAMSETTY S , Dixit NM
    ESTIMATING FREQUENCIES OF MINORITY NEVIRAPINE RESISTANT STRAINS IN CHRONICALLY HIV-1 INFECTED INDIVIDUALS NAIVE TO NEVIRAPINE USING STOCHASTIC SIMULATIONS AND A MATHEMATICAL MODEL.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KIM EY , Bhattacharya T, Kunstman K, Swantek P, et al
    Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BANDARANAYAKE RM , Kolli M, King NM, Nalivaika E, et al
    The Effect of Clade Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance Pathways.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. STONER TD , Krauss S, Dubois RM, Negovetich NJ, et al
    Antiviral Susceptibility of Avian and Swine Influenza of the N1 Neuraminidase Subtype.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HURT AC , Nor'e SS, McCaw JM, Fryer HR, et al
    Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets using a competitive mixtures model.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. TEBIT DM , Lobritz M, Lalonde M, Immonen T, et al
    Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to non-nucleoside RT inhibitors.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. BAR-MAGEN T , Sloan RD, Donahue DA, Kuhl BD, et al
    Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase inhibitor.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. STANSELL E , Desrosiers RC
    Fundamental Difference in the Content of High-mannose Carbohydrate in the HIV-1 and HIV-2 Lineages.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
47. WANG J , Bambara RA, Dykes C
    Reduced Fitness in Cell Culture of Human Immunodeficiency Virus Type-1 (HIV-1) with Non-nucleoside Reverse Transcriptase Inhibitor Resistant Mutations Correlates with Relative Levels of Reverse Transcriptase Content and Ribonuclease H Activity in Viri
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: